These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24390132)

  • 1. Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.
    Miyai M; Matsumoto Y; Yamanishi H; Yamamoto-Tanaka M; Tsuboi R; Hibino T
    J Invest Dermatol; 2014 Jun; 134(6):1665-1674. PubMed ID: 24390132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation.
    Ramesh K; Matta SA; Chew FT; Mok YK
    Allergy; 2020 Feb; 75(2):403-411. PubMed ID: 31407378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
    Meyer-Hoffert U; Wu Z; Schröder JM
    PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
    Borgoño CA; Michael IP; Komatsu N; Jayakumar A; Kapadia R; Clayman GL; Sotiropoulou G; Diamandis EP
    J Biol Chem; 2007 Feb; 282(6):3640-52. PubMed ID: 17158887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.
    Deraison C; Bonnart C; Lopez F; Besson C; Robinson R; Jayakumar A; Wagberg F; Brattsand M; Hachem JP; Leonardsson G; Hovnanian A
    Mol Biol Cell; 2007 Sep; 18(9):3607-19. PubMed ID: 17596512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
    Kishibe M
    J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases.
    Meyer-Hoffert U; Wu Z; Kantyka T; Fischer J; Latendorf T; Hansmann B; Bartels J; He Y; Gläser R; Schröder JM
    J Biol Chem; 2010 Oct; 285(42):32174-81. PubMed ID: 20667819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis.
    Chavarria-Smith J; Chiu CPC; Jackman JK; Yin J; Zhang J; Hackney JA; Lin WY; Tyagi T; Sun Y; Tao J; Dunlap D; Morton WD; Ghodge SV; Maun HR; Li H; Hernandez-Barry H; Loyet KM; Chen E; Liu J; Tam C; Yaspan BL; Cai H; Balazs M; Arron JR; Li J; Wittwer AJ; Pappu R; Austin CD; Lee WP; Lazarus RA; Sudhamsu J; Koerber JT; Yi T
    Sci Transl Med; 2022 Dec; 14(675):eabp9159. PubMed ID: 36516271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
    Wiegmann H; Valentin F; Tarinski T; Liebau E; Loser K; Traupe H; Oji V
    Br J Dermatol; 2019 Nov; 181(5):999-1008. PubMed ID: 30801672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Spink6 in mouse skin: the conserved inhibitor of kallikrein-related peptidases is reduced by barrier injury.
    Fischer J; Wu Z; Kantyka T; Sperrhacke M; Dimitrieva O; Koblyakova Y; Ahrens K; Graumann N; Baurecht H; Reiss K; Schröder JM; Proksch E; Meyer-Hoffert U
    J Invest Dermatol; 2014 May; 134(5):1305-1312. PubMed ID: 24352040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
    Fortugno P; Bresciani A; Paolini C; Pazzagli C; El Hachem M; D'Alessio M; Zambruno G
    J Invest Dermatol; 2011 Nov; 131(11):2223-32. PubMed ID: 21697885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.
    Ishida-Yamamoto A; Deraison C; Bonnart C; Bitoun E; Robinson R; O'Brien TJ; Wakamatsu K; Ohtsubo S; Takahashi H; Hashimoto Y; Dopping-Hepenstal PJ; McGrath JA; Iizuka H; Richard G; Hovnanian A
    J Invest Dermatol; 2005 Feb; 124(2):360-6. PubMed ID: 15675955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
    Fortugno P; Furio L; Teson M; Berretti M; El Hachem M; Zambruno G; Hovnanian A; D'Alessio M
    Hum Mol Genet; 2012 Oct; 21(19):4187-200. PubMed ID: 22730493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
    McGovern JA; Meinert C; de Veer SJ; Hollier BG; Parker TJ; Upton Z
    Br J Dermatol; 2017 Jan; 176(1):145-158. PubMed ID: 27442805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
    Komatsu N; Saijoh K; Jayakumar A; Clayman GL; Tohyama M; Suga Y; Mizuno Y; Tsukamoto K; Taniuchi K; Takehara K; Diamandis EP
    J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomous effect of ultraviolet B on the expression of corneodesmosomal enzymes in human epidermal keratinocytes.
    Nin M; Katoh N; Kokura S; Handa O; Yoshikawa T; Kishimoto S
    J Dermatol Sci; 2009 Apr; 54(1):17-24. PubMed ID: 19118981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of SPINK6 by transglutaminases protects from epidermal proteases.
    Fischer J; Koblyakova Y; Latendorf T; Wu Z; Meyer-Hoffert U
    J Invest Dermatol; 2013 May; 133(5):1170-7. PubMed ID: 23303447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugimoto S; Morizane S; Nomura H; Kobashi M; Sugihara S; Iwatsuki K
    J Dermatol Sci; 2018 Nov; 92(2):181-187. PubMed ID: 30270115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.
    de Veer SJ; Furio L; Swedberg JE; Munro CA; Brattsand M; Clements JA; Hovnanian A; Harris JM
    J Invest Dermatol; 2017 Feb; 137(2):430-439. PubMed ID: 27697464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugihara S; Sugimoto S; Tachibana K; Kobashi M; Nomura H; Miyake T; Hirai Y; Yamasaki O; Morizane S
    J Dermatol Sci; 2019 Oct; 96(1):26-32. PubMed ID: 31501002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.